Icici Prudential Nifty Pharma Index Fund Datagrid
Category Index Fund
BMSMONEY Rank 4
Rating
Growth Option 14-05-2026
NAV ₹18.57(R) +2.73% ₹18.98(D) +2.73%
Returns 1Y 3Y 5Y 7Y 10Y
Lumpsum Regular 13.81% 24.29% -% -% -%
Direct 14.52% 25.07% -% -% -%
Benchmark
SIP (XIRR) Regular 18.5% 15.72% -% -% -%
Direct 19.24% 16.45% -% -% -%
Ratio Sharpe Ratio Sortino Ratio Sterling Ratio Jensen's Alpha Treynor Ratio
0.9 0.47 0.86 -% -
Risk STD. Dev VaR 1Y95% Max DD Beta Semi Devi.
16.77% -19.17% -15.25% - 11.88%
Fund AUM As on: 30/12/2025 92 Cr
Top Index Fund
Fund Name Rank Rating
Motilal Oswal S&P 500 Index Fund 1
ICICI PRUDENTIAL NASDAQ 100 INDEX FUND 2
Edelweiss MSCI India Domestic & World Healthcare 45 Index Fund 3
ICICI Prudential Nifty Pharma Index Fund 4
Kotak Nifty SDL Apr 2027 Top 12 Eq Wt Index Fund 5
Axis CRISIL IBX SDL May 2027 Index Fund 6
Mirae Asset Nifty SDL Jun 2027 Index Fund 7
Aditya Birla Sun Life CRISIL IBX 60:40 SDL + AAA PSU - Apr 2027 Index Fund 8
ICICI Prudential Nifty SDL Sep 2027 Index Fund 9
Navi Nifty India Manufacturing Index Fund 10
Nippon India Nifty AAA CPSE Bond Plus SDL - Apr 2027 Maturity 60:40 Index Fund 11
SBI CPSE Bond Plus SDL Sep 2026 50:50 Index Fund 12
Aditya Birla Sun Life Nifty SDL Plus PSU Bond Sep 2026 60:40 Index Fund 13
ICICI Prudential Nifty Auto Index Fund 14
ICICI Prudential PSU Bond plus SDL 40:60 Index Fund - Sep 2027 15
Aditya Birla Sun Life Nifty SDL Apr 2027 Index Fund 16
- 17
Tata Nifty SDL Plus AAA PSU Bond Dec 2027 60: 40 Index Fund 18
Bandhan CRISIL Gilt 2027 Index Fund 19
DSP Nifty SDL Plus G-Sec Jun 2028 30:70 Index Fund 20
Bandhan CRISIL Gilt 2028 Index Fund 21

NAV Date: 14-05-2026

Scheme Name NAV Rupee Change Percent Change
ICICI Prudential Nifty Pharma Index Fund - IDCW 18.57
0.4900
2.7300%
ICICI Prudential Nifty Pharma Index Fund - Growth 18.57
0.4900
2.7300%
ICICI Prudential Nifty Pharma Index Fund - Direct Plan - IDCW 18.98
0.5000
2.7300%
ICICI Prudential Nifty Pharma Index Fund - Direct Plan - Growth 18.98
0.5000
2.7300%

Review Date: 14-05-2026

Investors beware: Mutual Fund investments are subject to market risks. Please read the scheme related documents carefully.

Data Source: www.amfiindia.com

SEBI Categorization


KPIs* Fund Benchmark Cat. Avg Min | Max Rank (In Cat.) Performance
1M Return % 9.32
0.42
-13.15 | 15.65 3 | 240 Very Good
3M Return % 9.34
-2.41
-16.49 | 16.27 9 | 238 Very Good
6M Return % 7.20
-3.77
-24.53 | 27.28 14 | 233 Very Good
1Y Return % 13.81
2.55
-26.77 | 54.73 18 | 211 Very Good
3Y Return % 24.29
14.18
0.27 | 36.40 5 | 106 Very Good
1Y SIP Return % 18.50
-0.71
-38.14 | 45.46 13 | 205 Very Good
3Y SIP Return % 15.72
6.98
-15.02 | 33.41 4 | 103 Very Good
Standard Deviation 16.77
13.58
0.49 | 22.47 68 | 102 Average
Semi Deviation 11.88
10.42
0.33 | 16.92 58 | 102 Average
Max Drawdown % -15.25
-16.43
-31.62 | 0.00 39 | 102 Good
VaR 1 Y % -19.17
-21.49
-38.54 | 0.00 25 | 102 Very Good
Average Drawdown % -6.56
-7.11
-14.55 | 0.00 44 | 102 Good
Sharpe Ratio 0.90
0.63
-0.17 | 2.35 20 | 102 Very Good
Sterling Ratio 0.86
0.50
0.04 | 1.20 4 | 102 Very Good
Sortino Ratio 0.47
0.36
-0.02 | 1.97 20 | 102 Very Good
Return data last Updated On : May 14, 2026.
Other parameters, fund ranking, non return related analysis are updated after every month end. Last Updated On : March 30, 2026
KPIs: Key Performance Indicators

Rotate the phone! Best viewed in landscape mode on mobile.
KPIs* Fund Benchmark Cat. Avg Min | Max Rank (In Cat.) Performance
1M Return % 9.37 0.46 -13.11 | 15.70 3 | 248 Very Good
3M Return % 9.51 -2.25 -16.36 | 16.44 9 | 246 Very Good
6M Return % 7.54 -3.49 -24.28 | 27.60 14 | 240 Very Good
1Y Return % 14.52 3.08 -26.29 | 55.48 18 | 212 Very Good
3Y Return % 25.07 14.71 0.78 | 37.02 5 | 106 Very Good
1Y SIP Return % 19.24 -0.28 -37.72 | 46.20 13 | 208 Very Good
3Y SIP Return % 16.45 7.51 -14.53 | 34.02 4 | 102 Very Good
Standard Deviation 16.77 13.58 0.49 | 22.47 68 | 102 Average
Semi Deviation 11.88 10.42 0.33 | 16.92 58 | 102 Average
Max Drawdown % -15.25 -16.43 -31.62 | 0.00 39 | 102 Good
VaR 1 Y % -19.17 -21.49 -38.54 | 0.00 25 | 102 Very Good
Average Drawdown % -6.56 -7.11 -14.55 | 0.00 44 | 102 Good
Sharpe Ratio 0.90 0.63 -0.17 | 2.35 20 | 102 Very Good
Sterling Ratio 0.86 0.50 0.04 | 1.20 4 | 102 Very Good
Sortino Ratio 0.47 0.36 -0.02 | 1.97 20 | 102 Very Good
Return data last Updated On : May 14, 2026.
Other parameters, fund ranking, non return related analysis are updated after every month end. Last Updated On : March 30, 2026
KPIs: Key Performance Indicators

Disclaimer: Past performance may or may not be sustained in future and should not be used as a basis for comparison with other investments. Returns for periods above 1 year are annualised.


Date Icici Prudential Nifty Pharma Index Fund NAV Regular Growth Icici Prudential Nifty Pharma Index Fund NAV Direct Growth
14-05-2026 18.5706 18.977
13-05-2026 18.077 18.4723
12-05-2026 18.0358 18.4298
11-05-2026 18.285 18.6842
08-05-2026 18.241 18.6382
07-05-2026 18.2606 18.6578
06-05-2026 18.2423 18.6388
05-05-2026 17.8334 18.2207
04-05-2026 17.7634 18.1489
30-04-2026 17.6082 17.9889
29-04-2026 17.6034 17.9838
28-04-2026 17.5268 17.9051
27-04-2026 17.5376 17.9158
24-04-2026 17.0926 17.4603
23-04-2026 17.4008 17.7748
22-04-2026 16.9995 17.3645
21-04-2026 16.9871 17.3516
20-04-2026 17.0014 17.3659
17-04-2026 17.0335 17.3977
16-04-2026 17.0097 17.3731
15-04-2026 16.988 17.3506

Fund Launch Date: 14/Dec/2022
Fund Category: Index Fund
Investment Objective: The objective of the Scheme is to invest in companies whose securities are included in Nifty Pharma Index and subject to tracking errors, to endeavor to achieve the returns of the above index. This would be done by investing in all the stocks comprising the Nifty Pharma Index in the same weightage that they represent in Nifty Pharma Index. However, there is no assurance or guarantee that the investment objective of the scheme shall be achieved.
Fund Description: An open ended Index scheme replicating Nifty Pharma Index
Fund Benchmark: Nifty Pharma TRI
Source: Fund FactSheet

Disclaimer: NO INVESTMENT ADVICE. The Content is for informational purposes only.